Form 4: Third Harmonic Bio Executive Receives Stock Options and Restricted Stock Units
SEC Form 4 Filing
Julie Person, Chief Administrative Officer of Third Harmonic Bio, was granted stock options and restricted stock units as part of the company's annual equity refresh.
Summary
- Julie Person, the Chief Administrative Officer of Third Harmonic Bio, received stock options and restricted stock units on January 15, 2025.
- The stock options grant is for 100,000 shares with an exercise price of $6.
- These options vest over four years, with an initial 2.0833% vesting on February 15, 2025, and then 2.0833% monthly thereafter.
- The restricted stock unit grant is for 12,500 shares.
- These RSUs vest over four years, with 1/4 vesting on February 15, 2026, and then 1/4 annually thereafter.
- Both grants are subject to continued service through each vesting date.
Sentiment
Score: 7
Explanation: The document reflects a standard practice of executive compensation, which is generally viewed positively for aligning interests. There are no negative implications.
Positives
- The equity grants align the executive's interests with the company's long-term performance.
- The vesting schedule encourages continued service and commitment from the executive.
Industry Context
Equity grants are a common practice in the biotechnology industry to attract and retain key talent.
Comparison to Industry Standards
- Equity grants are a standard form of compensation for executives in the biotech industry, often including a mix of stock options and restricted stock units.
- Vesting schedules of four years are typical to ensure long-term commitment from executives.
- The specific amounts and terms of the grants would need to be compared to similar companies to assess if they are in line with industry standards.
Stakeholder Impact
- Shareholders may view the equity grants as a positive sign of management's commitment.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 12/17/2024 | Board of directors approved the equity awards. |
| 01/15/2025 | Effective grant date of stock options and restricted stock units. |
| 02/15/2025 | First vesting date for 2.0833% of the stock options. |
| 02/15/2026 | First vesting date for 1/4 of the restricted stock units. |
| 01/14/2035 | Expiration date of the stock options. |
Keywords
stock options, restricted stock units, equity grants, executive compensation, vesting, Third Harmonic Bio, THRD
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.